Osimertinib 40 mg Tablet
Osimertinib 40 mg Tablet
Osimertinib 40 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Third-Generation EGFR Tyrosine Kinase Inhibitor — Antineoplastic
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Osimertinib 40 mg Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- First-line treatment of EGFR-mutated advanced non-small cell lung cancer
- EGFR T790M-positive lung cancer progressing on earlier EGFR inhibitors
- Adjuvant therapy after complete surgical removal of EGFR-mutated NSCLC
Mechanism of Action
Osimertinib irreversibly binds mutant EGFR, including common sensitising mutations and the T790M resistance mutation, blocking signals that drive cancer cell growth. It has relatively little effect on normal EGFR and penetrates the brain well.
Dosage & Administration
- Dosage of Osimertinib 40 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Diarrhoea
- Skin rash, dry skin and itching
- Nail-fold inflammation (paronychia)
- Mouth sores (stomatitis)
- Low blood counts
Contraindications
- Interstitial lung disease; stop if new breathing symptoms develop
- QT prolongation and heart failure; monitor ECG and cardiac function
- Pregnancy: can harm the foetus; effective contraception required
- Use only after confirmed EGFR mutation testing
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
PCD Pharma Franchise & Third Party Manufacturing — Osimertinib Tablet
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Osimertinib 40 mg. It is a third-generation EGFR tyrosine kinase inhibitor, used for first-line treatment of EGFR-mutated advanced non-small cell lung cancer and EGFR T790M-positive lung cancer progressing on earlier EGFR inhibitors. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Osimertinib Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Osimertinib Tablet in India?
Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Osimertinib Tablet in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Osimertinib Tablet used for?
Osimertinib Tablet is used for first-line treatment of EGFR-mutated advanced non-small cell lung cancer; EGFR T790M-positive lung cancer progressing on earlier EGFR inhibitors; adjuvant therapy after complete surgical removal of EGFR-mutated NSCLC. It should be used as advised by a registered medical practitioner.
Is Osimertinib Tablet available for PCD pharma franchise on monopoly basis?
Yes. Osimertinib 40 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Osimertinib for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Osimertinib Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Osimertinib Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Osimertinib?
Osimertinib is a third-generation EGFR tyrosine kinase inhibitor (therapeutic class: Third-Generation EGFR Tyrosine Kinase Inhibitor — Antineoplastic).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Osimertinib Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Osimertinib 40 mg Tablet?